Suven Pharmaceuticals Limited (SUVENPHAR.BO)

INR 1222.9

(-1.92%)

Market Cap (In INR)

311.3 Billion

Revenue (In INR)

10.51 Billion

Net Income (In INR)

3 Billion

Avg. Volume

21.62 Thousand

Currency
INR
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
586.1-1359.0
PE
-
EPS
-
Beta Value
1.338
ISIN
INE03QK01018
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Dr. Sudhir Kumar Singh Ph.D.
Employee Count
-
Website
https://www.suvenpharm.com
Ipo Date
Details
Suven Pharmaceuticals Limited operates as a bio-pharmaceutical company in India, the United States, Europe, and internationally. It develops, manufactures, and sells new chemical entity-based intermediates, active pharmaceutical ingredients, specialty chemicals, and formulated drugs under contract research and manufacturing services for pharmaceutical, biotechnology, and chemical companies. The company was incorporated in 2018 and is headquartered in Hyderabad, India. Suven Pharmaceuticals Limited is a subsidiary of Jasti Property and Equity Holdings Private Limited. As of September 29, 2023, Suven Pharmaceuticals Limited operates as a subsidiary of Berhyanda Limited.